E79.81
Aicardi-Goutières syndrome
Clinical Classification Guidelines
Medical Intelligence & Overview
Aicardi-Goutières syndrome is a rare genetic disorder primarily affecting the brain, immune system, and skin. Characterized by inflammation within the brain and other neurological issues, it often presents in infancy or early childhood. The condition can vary greatly in severity and symptoms, but understanding its core features helps in anticipating potential health challenges related to the syndrome.
Causes & Symptoms
Clinical Causes: Mutations in specific genes that influence immune response and brain development Inheritance patterns, often autosomal recessive, meaning a child inherits mutated genes from both parents
Key Symptoms: Encephalopathy or neurological decline Inflammation of the brain causing developmental delays Seizures Poor feeding and irritability in infants Leukodystrophy or white matter abnormalities seen in brain scans Rising levels of interferon-alpha in the blood and cerebrospinal fluid Skin abnormalities, such as fish-scale-like skin lesions Organ involvement may include liver and spleen enlargement
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment, neuroimaging, genetic testing, and laboratory analysis. Brain imaging typically reveals white matter changes. Blood and cerebrospinal fluid tests may show elevated interferon-alpha levels. Genetic testing confirms mutations associated with the syndrome, assisting in accurate diagnosis.
Treatment Protocols: Currently, there is no cure for Aicardi-Goutières syndrome. Treatment strategies are focused on managing symptoms and improving quality of life. This can include:
Clinical Advice & FAQs
Billing Guidance
Is E79.81 a billable ICD-10 code?
Yes, E79.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E79.81?
Clinical documentation must specify the nature of Aicardi-Goutières syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference